Comparative Evaluation of Mineralized Bone Allografts for Spinal Fusion Surgery.
PMID: 37504879 ·
Paul J Hubbell, Brandon Roth, Jon E Block
JournalJournal of functional biomaterials
Year
PMID37504879
Abstract
The primary objective of this review is to evaluate whether the degree of processing and the clinical utility of commercially available mineralized bone allografts for spine surgery meet the 2020 US Food and Drug Administration's (FDA) guideline definitions for minimal manipulation and homologous use, respectively. We also assessed the consistency of performance of these products by examining the comparative postoperative radiographic fusion rates following spine surgery. Based on the FDA's crit
Official Source
View on PubMed →Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.